相似文献
1
Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
Proc Natl Acad Sci U S A. 1974 Apr;71(4):1422-6. doi: 10.1073/pnas.71.4.1422.
2
Antibodies to Epstein-Barr virus associated antigens in Burkitt's lymphoma.
Bibl Haematol. 1973;39:813-7. doi: 10.1159/000427909.
3
The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
Hamatol Bluttransfus. 1974;14:129-32.
4
Epstein-Barr virus-associated and other antiviral antibodies during intense BCG administration to patients with Burkitt's lymphoma in remission.
J Natl Cancer Inst. 1978 Jan;60(1):31-7. doi: 10.1093/jnci/60.1.31.
5
Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma.
Int J Cancer. 1979 Nov 15;24(5):567-71. doi: 10.1002/ijc.2910240508.
6
[Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino. 1972 Sep-Oct;65(9):228-32.
7
Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells.
J Natl Cancer Inst. 1973 Jul;51(1):45-56. doi: 10.1093/jnci/51.1.45.
8
Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma.
J Natl Cancer Inst. 1973 Oct;51(4):1319-21. doi: 10.1093/jnci/51.4.1319.
9
Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens.
J Natl Cancer Inst. 1976 Nov;57(5):1051-6. doi: 10.1093/jnci/57.5.1051.
10
Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma.
J Natl Cancer Inst. 1978 May;60(5):941-6. doi: 10.1093/jnci/60.5.941.
本文引用的文献
1
Quantitative studies on the multiplication of neoplastic cells in vivo. IV. Influence of doubled chromosome number on growth rate and final population size.
J Natl Cancer Inst. 1957 Jul;19(1):13-31.
2
Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival.
Cancer Res. 1967 Dec;27(12):2578-615.
3
Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.
J Natl Cancer Inst. 1969 Nov;43(5):1147-57.
4
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372-5. doi: 10.1073/pnas.68.6.1372.
5
EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence.
Int J Cancer. 1969 Jul 15;4(4):416-21. doi: 10.1002/ijc.2910040406.
6
Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.
Int J Cancer. 1973 Jul 15;12(1):115-23. doi: 10.1002/ijc.2910120112.
7
Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma.
J Natl Cancer Inst. 1973 Oct;51(4):1319-21. doi: 10.1093/jnci/51.4.1319.
8
Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells.
J Natl Cancer Inst. 1973 Jul;51(1):45-56. doi: 10.1093/jnci/51.1.45.
9
Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors.
J Natl Cancer Inst. 1973 May;50(5):1163-73. doi: 10.1093/jnci/50.5.1163.
10
Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
Nat New Biol. 1972 Aug 9;238(84):185-6. doi: 10.1038/newbio238185a0.
Zotero 插件